In agreement with the Ing4−/− model, small interfering RNA-mediated silencing of ING4 prevents normal cell cycle progression of human breast cancer MCF7 cells, marked with an accumulation in the G2/M phase of the cell cycle [6]. This evidence concerns the gene ING4 and breast carcinoma.